Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements (French, HTML)
Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements: French HTML file. From Health Canada, updated Oct 2023. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2023-10-28
This section of the guidance outlines requirements for the licence holder after authorization of the clinical trials.
Data overview
- Formats
- HTML
- File languages
- French
- Available actions
- Access original file